One shot, two viruses: new vaccine targets RSV and hMPV in seniors
NCT ID NCT06583031
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tested a new vaccine designed to protect against both RSV and hMPV, two common respiratory viruses. 385 healthy adults aged 60 to 75 received a single injection of different doses. The main goals were to check safety and measure the immune response. Results will help decide if further testing is warranted.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
RSV/hMPV vaccine candidate (different doses)
What this could lead to
If successful, this could lead to a single vaccine that protects older adults against both RSV and hMPV respiratory infections.
What could go wrong
This is an early Phase 1 trial focused on safety and immune response, not yet on preventing illness. The vaccine may not produce strong enough immunity or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RSV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site # 031001
Brookvale, New South Wales, 2100, Australia
-
Site # 0361002
Wollongong, New South Wales, 2500, Australia
-
Site # 0361003
Herston, Queensland, 4006, Australia
-
Site # 0361004
Botany, New South Wales, 2019, Australia
-
Site # 0361005
South Brisbane, Queensland, 4101, Australia
-
Site # 0361006
Miranda, New South Wales, 2228, Australia